Health Passport App a Key Next-Step to Reopening Global Economy
TAMPA, FL / ACCESSWIRE / February 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that the Company has appointed technology entrepreneur and industry thought leader James Ram to lead the Company's newly launched MedCheks LLC (MedCheks) subsidiary in its efforts to bring a Digital Health Passport to market - allowing the holder to display vaccination status and test results for travel or access to events and public facilities.
James Ram brings more than 25 years of leadership experience in the travel, tourism and location-based entertainment industry to Trxade, with experience spanning strategic management, business development, investor relations and data management. Prior to joining Trxade, Ram founded Indusa Global, a highly specialized information systems firm for the tourism and national security industry, where he led the Company's diversification into healthcare, growing the Company's fledging healthcare business from a single installation to 54 satellite locations servicing over 2,500 facilities. Ram brings a keen understanding of national security to Trxade, as he implemented the first fully biometric ePassport with facial scans and fingerprints in the Americas.
An accomplished strategist with global experience, early on in his career James Ram was honored to be the youngest Senior Fellow with the United Nations Institute of Training and Research. His drive to positively impact the world led him to speaking at many conferences including the World Economic Forum and G15 Summit attended by 17 Heads of State and the United Nations World Tourism Conference.
James Ram will lead the Company's new MedCheks subsidiary as it seeks to bring its first product, a Digital Health Passport, to market. MedCheks Health Passport will store an individual's health records safely in one place, allowing the holder to display vaccination status and test results for travel or access to events and public facilities. MedCheks will leverage both state-of-the-art encryption and blockchain technology to conceal all private health data, allowing for the secure exchange of data between passport holder and verifier.
"I am pleased to announce the introduction of MedCheks and its first product, a Digital Health Passport, allowing the global economy the means by which to safely reopen," said Suren Ajjarapu, Chief Executive Officer of Trxade Group. "Finding a technology leader with a successful track record in innovation like James Ram was critical, as his broad experience with privacy, security and excellent global reputation will prove important as we launch this exciting new product."
"I am truly honored to lead MedCheks, having been very fortunate in my career to be on the forefront of secure technology systems and their implementation - which allowed me to develop a terrific network of colleagues around the world," said James Ram, President of MedCheks, a Trxade Group Company. "Like everyone, I eagerly await the reopening of the global economy to safe travel and recreation. I look forward to working closely with Suren to introduce this incredible new product, making a global reopening possible while concurrently creating value for Trxade Group shareholders."
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ:MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group's virtual wholesale division, and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit us at www.trxade.com at www.bonumhealth.com or at www.medcheks.com.
Forward-Looking Statements
This press release may contain forward-looking statements, including information about management's view of Trxade's future expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the "Act"). In particular, when used in the preceding discussion, the words "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of Trxade, its divisions and concepts to be materially different than those expressed or implied in such statements. These risk factors and others are included from time to time in filings made by Trxade with the Securities and Exchange Commission, including, but not limited to, in the "Risk Factors" sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. Other unknown or unpredictable factors also could have material adverse effects on Trxade's future results and/or could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. Trxade cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
Investor Relations:
Lucas Zimmerman
Senior Vice President
MZ Group - MZ North America
(949) 259-4987
[email protected]
www.mzgroup.us
SOURCE: Trxade Group, Inc.